Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease
- 1 October 1998
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 115 (4) , 813-821
- https://doi.org/10.1016/s0016-5085(98)70251-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Overwhelming Varicella Pneumonia in a Patient with Crohnʼs Disease Treated with 6-MercaptopurineJournal of Pediatric Gastroenterology and Nutrition, 1995
- Extraintestinal Manifestations of Inflammatory Bowel Disease in ChildrenJournal of Pediatric Gastroenterology and Nutrition, 1994
- Longitudinal Growth in Children and Adolescents with Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition, 1994
- Growth Failure in Pediatric Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition, 1993
- Risk factors for small bowel cancer in Crohn's diseaseDigestive Diseases and Sciences, 1992
- Immunology of Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition, 1991
- Azathioprine in the treatment of children with inflammatory bowel diseaseThe Journal of Pediatrics, 1990
- Growth and Development in Chronic Inflammatory Bowel DiseaseActa Paediatrica, 1990
- Favorable effect of 6-Mercaptopurine on fistulae of Crohn's diseaseDigestive Diseases and Sciences, 1985
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980